Skip to main content
    U

    Unicycive Therapeutics Inc (UNCY)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.70
    +0.15 (+4.23%)

    Market Cap: $97.25M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Unicycive Therapeutics Inc (UNCY) Earnings: Report Dates and Results

    Updated Nov 11, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Unicycive Therapeutics (UNCY) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, Unicycive Therapeutics reported EPS of -$0.39, below the -$0.33 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    36%(8/22)
    Avg Surprise
    -12.78%

    Upcoming Estimates

    Reports Mar 29, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.34
    Range-$0.42 - -$0.26
    11 analysts
    Revenue Consensus
    $321.00K
    RangeN/A
    11 analysts

    Next Report

    UNCY has an expected report date of Mar 29, 2027.

    Earnings History

    Of the 22 quarters below that had an estimate, UNCY beat 8, missed 13 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2024, when EPS landed 373.52% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.39-$0.33-$0.66 - -$0.23-18.18%MissN/A91 up, 0 downNov 11, 2026
    Jun 30, 2026-$0.06-$0.34-$0.37 - -$0.30+82.35%BeatN/A72 up, 1 downAug 12, 2026
    Mar 31, 2026-$0.54-$0.48-$1.23 - -$0.29-11.47%MissN/A105 up, 1 downMay 12, 2026
    Dec 31, 2025-$0.82-$0.46-$0.79 - -$0.31-78.26%Miss-428.0%80 up, 0 downMar 30, 2026
    Sep 30, 2025-$0.33-$0.53-$0.74 - -$0.35+37.74%BeatN/A82 up, 0 downNov 12, 2025
    Jun 30, 2025-$0.52-$0.70-$0.80 - -$0.50+25.71%Beat-134.7%7N/AAug 14, 2025
    Mar 31, 2025-$0.50-$0.62-$0.80 - -$0.30+19.35%BeatN/A51 up, 2 downMay 14, 2025
    Dec 31, 2024$0.25-$0.09-$0.09 - -$0.05+373.52%BeatN/A53 up, 0 downMar 27, 2025
    Sep 30, 2024-$0.50-$1.52-$2.80 - -$0.70+67.11%BeatN/A64 up, 2 downNov 12, 2024
    Jun 30, 2024$1.50-$1.92-$2.80 - -$0.60+178.13%BeatN/A60 up, 0 downAug 14, 2024
    Mar 31, 2024-$6.10-$1.55-$2.10 - -$0.90-293.55%MissN/A41 up, 0 downMay 13, 2024
    Dec 31, 2023-$0.22-$0.17-$0.18 - -$0.13-29.41%MissN/A40 up, 0 downMar 28, 2024
    Sep 30, 2023-$1.30-$1.30-$1.30 - -$1.100.00%In lineN/A20 up, 0 downNov 14, 2023
    Jun 30, 2023-$2.90-$3.20-$4.40 - -$0.90+9.38%BeatN/A50 up, 0 downAug 14, 2023
    Mar 31, 2023-$9.70-$3.72-$4.10 - -$3.10-160.75%MissN/A40 up, 0 downMay 16, 2023
    Dec 31, 2022-$0.35-$0.24-$0.38 - -$0.16-45.83%MissN/A50 up, 0 downMar 31, 2023
    Sep 30, 2022-$3.70-$2.80-$4.50 - -$1.50-32.14%MissN/A30 up, 0 downNov 14, 2022
    Jun 30, 2022-$2.40-$2.27N/A-5.73%MissN/AN/A0 up, 0 downAug 15, 2022
    Mar 31, 2022-$2.40-$1.90-$2.00 - -$1.30-26.32%MissN/A20 up, 0 downMay 12, 2022
    Dec 31, 2021-$0.24-$0.13-$0.16 - -$0.11-84.62%MissN/A2N/AMar 31, 2022
    Sep 30, 2021-$3.70-$1.00-$1.10 - -$1.00-270.00%MissN/A20 up, 0 downNov 11, 2021
    Jun 30, 2021-$1.30-$1.10-$1.10 - -$1.10-18.18%MissN/A1N/AAug 16, 2021
    Mar 31, 2021-$0.07N/AN/AN/AN/AN/AN/AN/AMay 21, 2021
    Sep 30, 2020-$0.06N/AN/AN/AN/AN/AN/AN/ANov 2, 2020
    Jun 30, 2020-$0.03N/AN/AN/AN/AN/AN/AN/ASep 15, 2020
    Last 25 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$2.17, after -$4.85 the year before. It was -$5.40 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$2.17N/A
    Dec 31, 2024-$4.85N/A
    Dec 31, 2023-$14.12N/A
    Dec 31, 2022-$8.85N/A
    Dec 31, 2021-$5.40N/A

    Frequently Asked Questions About UNCY

    When is Unicycive Therapeutics's next earnings date?

    Unicycive Therapeutics's next earnings report is expected for Mar 29, 2027.

    Did UNCY beat earnings estimates last quarter?

    No. Unicycive Therapeutics reported EPS of -$0.39 for the quarter ended Sep 30, 2026, below the -$0.33 estimate by 18.18%.

    What EPS do analysts expect from UNCY next quarter?

    The consensus EPS estimate for Unicycive Therapeutics for the quarter ending Dec 31, 2026 is -$0.34 from 11 analysts, with estimates from -$0.42 to -$0.26.

    How often does UNCY beat earnings estimates?

    Unicycive Therapeutics beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +53.85%.